Bahamas, The vs Canada: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Bahamas, The
85.0%
in 2025
Canada
85.0%
in 2025
Bahamas, The rank
94th
Canada rank
94th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Bahamas, The
- Canada
How they compare
Bahamas, The currently reports 85.0% against 85.0% in Canada, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Canada ahead.
Bahamas, The ranks 94th and Canada ranks 94th of 192 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahamas, The | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 46.0% | 44.5% | Canada |
| 2010s | 69.3% | 76.1% | 6.8% | Canada |
| 2020s | 83.0% | 84.7% | 1.7% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bahamas, The or Canada?
- Bahamas, The, at 85.0% against 85.0% in Canada as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bahamas, The and Canada?
- 0.0%, with Bahamas, The ahead.
- How many years of comparable data are there for Bahamas, The and Canada?
- 18 years are reported by both, from 2008 to 2025.
- How do Bahamas, The and Canada rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bahamas, The ranks 94th and Canada ranks 94th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.